Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

The Denver doom lords are preparing to release a double LP, Observance, on Halloween via Relapse Records, and the latest death-sludge tome is unlike anything the trio’s done in the past thirteen years ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

Virginia Beach-based Born Primitive is bringing its patriot-inspired workout apparel to the Hilltop shopping district. The e-commerce clothing brand, co-founded in a garage in 2014 by former Navy SEAL ...

Wondering where to stream 'Primitive War' on your favorite screen? Below, you’ll find ways to watch including rental, purchase, and subscription options, so you can find the right fit. Right now in ...

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...

This week, I had to make one of the most difficult decisions of my career: saying goodbye to 20% of the team at Recursion. The process was extraordinarily painful, and the costs were heartbreakingly ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...